Cargando…
Harnessing the Therapeutic Potential of Th17 Cells
Th17 cells provide protective immunity to infections by fungi and extracellular bacteria as well as cancer but are also involved in chronic inflammation. The cells were first identified by their ability to produce interleukin 17A (IL-17A) and, subsequently, associated with chronic inflammation and a...
Autores principales: | Bystrom, Jonas, Taher, Taher E., Muhyaddin, M. Sherwan, Clanchy, Felix I., Mangat, Pamela, Jawad, Ali S., Williams, Richard O., Mageed, Rizgar A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4460252/ https://www.ncbi.nlm.nih.gov/pubmed/26101460 http://dx.doi.org/10.1155/2015/205156 |
Ejemplares similares
-
Response to Treatment with TNFα Inhibitors in Rheumatoid Arthritis Is Associated with High Levels of GM-CSF and GM-CSF(+) T Lymphocytes
por: Bystrom, Jonas, et al.
Publicado: (2017) -
Metabolic requirements of Th17 cells and of B cells: Regulation and defects in health and in inflammatory diseases
por: Bystrom, Jonas, et al.
Publicado: (2022) -
Th17 Lymphocytes in Respiratory Syncytial Virus Infection
por: Bystrom, Jonas, et al.
Publicado: (2013) -
Intracellular B Lymphocyte Signalling and the Regulation of Humoral Immunity and Autoimmunity
por: Taher, Taher E., et al.
Publicado: (2017) -
Favorable therapeutic response of osteoporosis patients to treatment with intravenous zoledronate compared with oral alendronate
por: Al-Bogami, Mohammed M., et al.
Publicado: (2015)